Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PIII files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsP3 Health Partners regains Nasdaq compliance after failing minimum financial standards
Filed May 26, 2026 · Period ending May 20, 2026 · ~1 min read
Key Changes
-
high
Nasdaq confirmed on May 20, 2026 that P3 Health Partners has returned to compliance with continued listing requirements under Rule 5550(b)(2), resolving a deficiency first disclosed in November 2025.
Item 3.01 verify on EDGAR → -
medium
The company had previously failed to meet at least one of three minimum thresholds: $2.5 million stockholders' equity, $35 million market value of listed securities, or $500,000 net income from continuing operations.
Item 3.01 verify on EDGAR → -
high
The compliance restoration eliminates the immediate risk of delisting from Nasdaq, which would have severely impaired liquidity and institutional ownership.
Item 3.01 verify on EDGAR →
Summary
P3 Health Partners has successfully regained compliance with Nasdaq's continued listing requirements after a six-month period of deficiency. The company received official notification from Nasdaq on May 20, 2026, confirming it now meets the financial standards under Rule 5550(b)(2).
This follows a November 2025 warning that the company failed to satisfy minimum thresholds for stockholders' equity, market value, or profitability. For retail investors, this is significant because it removes the immediate threat of delisting, which would have made shares harder to trade and likely triggered forced selling by institutional investors restricted from holding unlisted securities.
The company appears to have improved its financial position sufficiently to meet at least one of the three alternative standards. Investors should monitor upcoming quarterly filings to confirm the financial improvements are sustainable. Watch whether the company maintains positive stockholders' equity or profitability in future quarters, as falling back into non-compliance could restart the delisting process with less tolerance from Nasdaq.
Section-by-Section Diff
Event · Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule
P3 Health Partners regained compliance with Nasdaq listing requirements after previously failing to meet minimum financial standards.
Added in current filing · verify on EDGAR →
On May 20, 2026, the Company received a letter from the Staff notifying the Company that, based on the Company’s Form 8-K filed with the SEC on May 15, 2026, the Staff has determined that the Company complies with Nasdaq Listing Rule 5550(b) (2) and has now returned to compliance with Nasdaq continued listing requirements.
The company received official notification from Nasdaq that it has regained compliance with continued listing requirements under Rule 5550(b)(2). This resolves a prior deficiency disclosed in November 2025 where the company failed to meet minimum standards for stockholders' equity, market value, or net income.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 28, 2026 · How we verify